DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr. Reddy's Laboratories
02 2Alfred E Tiefenbacher GmbH
03 1NanoAlvand
04 1Pharmathen SA
05 4Accord healthcare
06 1Alkem Laboratories
07 1Alphapharm PTY Ltd
08 2Apotex Inc
09 1Arrow Pharmaceuticals
10 1Aurobindo Pharma Limited
11 1Biocon
12 1Bionpharma
13 1Bluepharma
14 1CHEMO
15 1Chartwell Pharmaceuticals llc
16 2Cycle Pharmaceuticals
17 1Deva Holding AS
18 2Devatis AG
19 1EZRA VENTURES
20 1Forrester Pharma
21 1Glenmark Pharmaceuticals
22 1HEC Pharm
23 2Hetero Drugs
24 2Intas Pharmaceuticals
25 1JAMP PHARMA
26 1MSN Laboratories
27 2Mepha Pharma
28 1Neuraxpharm
29 9Novartis Pharmaceuticals Corporation
30 1ORIFARM GROUP AS
31 1Orchid Pharma
32 1Par Pharmaceutical
33 1Pharmacore Inc
34 1Pharmascience Inc.
35 1Prinston
36 4Sandoz B2B
37 1Standard Chem. & Pharm. Co., Ltd
38 2Sun Pharmaceutical Industries Limited
39 1Taro Pharmaceutical Industries
40 1Tecnimede
41 1Teva Pharma Australia
42 4Teva Pharmaceutical Industries
43 4Viatris
44 1Zydus Pharmaceuticals
01 1CAB
02 3CAP
03 11CAPSULE
04 23CAPSULE;ORAL
05 12Caps
06 6Capsule
07 1Capsule, hard
08 5Hard Capsule
09 1Hard Gelatin Capsule
10 2TABLET, ORALLY DISINTEGRATING;ORAL
11 7capsule
12 1Blank
01 3DISCN
02 1EU Approved
03 2EU Dossier Readiness-Q2 2018
04 4Generic
05 1Generic EU CTD
06 1Lead Market Dossiers- Filed
07 1Originator
08 10Prescription
09 19RX
10 31Blank
01 1ACH-FINGOLIMOD
02 1AKM Fingolimod
03 1APO-FINGOLIMOD
04 1Danelvin
05 1FILENGIA
06 3FINGOLIMOD
07 18FINGOLIMOD HYDROCHLORIDE
08 2Fingolimod Accord
09 2Fingolimod Devatis
10 1Fingolimod SUN
11 3Fingolimod Sandoz
12 2Fingolimod Viatris
13 2Fingolimod-Mepha
14 1Fingolimod-Teva
15 1Fynod
16 4GILENYA
17 5Gilenya
18 1Glomatin
19 1JAMP FINGOLIMOD
20 1MYLAN-FINGOLIMOD
21 1Myelenea
22 1PMS-FINGOLIMOD
23 1Pharmacor Fingolimod
24 1SANDOZ FINGOLIMOD
25 1TARO-FINGOLIMOD
26 2TASCENSO ODT
27 1TEVA-FINGOLIMOD
28 1Tugivin 0,5 mg
29 12Blank
01 8Australia
02 10Canada
03 2Germany
04 1Greece
05 4India
06 1Iran
07 1Norway
08 2Portugal
09 4South Africa
10 2Spain
11 12Switzerland
12 1Turkey
13 25USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2021-03-05
Application Number : 208000
Regulatory Info : RX
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Danelvin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q2 2018
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-10-28
Application Number : 207991
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-12-18
Application Number : 207993
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2024-02-28
Application Number : 207983
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2019-12-04
Application Number : 207979
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-06-29
Application Number : 207971
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-06-18
Application Number : 207985
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2021-11-10
Application Number : 207939
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-05-18
Application Number : 207933
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GILENYA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2010-09-21
Application Number : 22527
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : GILENYA
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.25MG BASE
Packaging :
Approval Date : 2018-05-11
Application Number : 22527
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FINGOLIMOD
Dosage Form : CAPSULE;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 207965
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FINGOLIMOD
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date :
Application Number : 207940
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2020-10-14
Application Number : 207994
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FINGOLIMOD HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE
Packaging :
Approval Date : 2023-12-06
Application Number : 207945
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
